ダウンロード数: 120
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
28_0383.pdf | 227.81 kB | Adobe PDF | 見る/開く |
タイトル: | 腎細胞癌に対する抗癌剤動脈内注入療法の検討 |
その他のタイトル: | CLINICAL STUDY OF INTRA-ARTERIAL INFUSION OF CANCER CHEMOTHERAPEUTIC DRUGS IN THE TREATMENT OF RENAL CELL CARCINOMA |
著者: | 林正, 健二 加納, 勝利 高橋, 茂樹 矢崎, 恒忠 小川, 由英 石川, 悟 根本, 真一 飯泉, 達夫 武島, 仁 北川, 龍一 |
著者名の別形: | Rinsho, Kenji Kano, Katsutoshi Takahashi, Shigeki Yazaki, Tsunetada Ogawa, Yoshihide Ishikawa, Satoru Nemoto, Shinichi Iizumi, Tatsuo Takeshima, Hitoshi Kitagawa, Ryuichi |
発行日: | Apr-1982 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 28 |
号: | 4 |
開始ページ: | 383 |
終了ページ: | 386 |
抄録: | Since 1977, 16 patients with renal cell carcinoma received intra-arterial infusion chemotherapy. Nine of the tumors were diagnosed to be at stage I, 2 at stage II and 5 at stage IV. For intra-arterial infusion a Teflon catheter was implanted into the abdominal aorta via the A. circumflexa femoris lateralis. After radical or palliative nephrectomy, MMC and 5-FU were infused once or twice a week; this therapy was continued for about one year. One patient with a stage I lesion and 4 patients with stage IV lesions died of cancer within 27 months after nephrectomy. Eleven of the patients who had stage I or II lesions are disease-free from 3 to 37 months after operation. Side effects were recognized in all cases. Myelosuppression and disorder of renal function were the main side effects, but they disappeared soon after cessation of chemotherapy. |
URI: | http://hdl.handle.net/2433/123074 |
出現コレクション: | Vol.28 No.4 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。